Newborn gut treatment study pulled before it even started
NCT ID NCT06547424
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 20 times
Summary
This study aimed to see if a supplement called chondroitin sulfate is safe for very small newborns with necrotizing enterocolitis (NEC), a severe gut infection. The plan was to give some babies the supplement and others a placebo, then compare death rates, need for surgery, and long-term development. However, the study was withdrawn before enrolling any participants, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTESTINAL ISCHEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Riley Hospital for Children
Indianapolis, Indiana, 46202, United States
Conditions
Explore the condition pages connected to this study.